menu

Hospital Acquired Disease Testing Market

Schedule Call

Hospital Acquired Disease Testing Market

Hospital Acquired Disease Testing Market by Product (Instruments, Reagents and Consumables) by Test Type (Molecular Diagnostics, Immunoassay, and Others), By Application (Disease Testing, and Drug-Resistance Testing), By Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections), By End User (Hospital, Standalone Laboratories, and Others) – Global Outlook & Forecast Period 2022-2030

GR - 293684 Category: Biotechnology

Number of pages: 100  |  Report Format: PDF  |  Published date: September 08, 2022

Historical Years – 2020  |  Base Year – 2021  |  Forecasted Years – 2022-2030


Hospital Acquired Disease Testing Market Scope

Report Attribute

Details

Market size value in 2021

USD 3.67 billion

Revenue forecast in 2030

USD 7.14 billion

Growth Rate

CAGR of 7.7% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Segments covered

Product, Test Type, Application, Infection Type, End User and Region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Report Overview

According to the deep-dive market assessment study conducted by Growth Plus Reports, the global hospital-acquired disease testing market was pegged at US$ 3.67 billion in 2021 and is expected to register a revenue CAGR of 7.7% to reach US$ 7.14 billion by 2030.

Market Fundamentals 

Nosocomial infection, also known as hospital-acquired disease, is a localized or systemic ailment in patients that develops because of infectious agents while receiving medical care and were not present at the time of admission. Longer hospital stays, antimicrobial resistance, permanent disabilities, and a higher mortality rate are all implications of hospital-acquired infections. Viruses, fungal parasites, and bacteria all serve as pathogens that cause illnesses that patients contract while hospitalized. Moreover, infections at the surgical wounds, pneumonia linked to ventilators, and urinary tract infections linked to catheters are among illnesses acquired in hospitals. Microarray, PCR, and solid phase hybridization are the methods utilized for disease testing, diagnosis, and prevention that are associated with hospital-acquired conditions.

[345679]

Market Dynamics

The prevalence of pathogens, bacterial, fungal, and viral diseases, as well as rising morbidity rates from infections around the globe, are some of the key factors influencing the global market revenue for hospital-acquired disease testing. Another significant factor is the lengthening of hospital stays, which are mostly brought on by hospital-acquired infections. Furthermore, the intensive care units (ICU) and emergency rooms have a higher risk of an HAI (ER). According to CDC estimates, 5% of hospitalized patients contract an HAI in some form within 72 hours of their admission. Excluded from consideration are infections that are still developing but are not yet clinically evident.

Market Ecosystem

The global hospital-acquired disease testing market is analyzed from six perspectives: product, test type, application, infection type, end user, and region.

Hospital-Acquired Disease Testing Market by Product

Based on product, the global hospital-acquired disease testing market is segmented into instruments, reagents, and consumables. 

The reagents segment dominates the market in terms of revenue share, owing to low awareness and a high prevalence of hospital-acquired illnesses in low and middle-income nations are attributed to the segment's revenue growth.

Hospital-Acquired Disease Testing Market by Test Type 

Based on test type, the global hospital-acquired disease testing market is segmented into molecular diagnostics, immunoassay, and others. 

During the forecast period, the immunoassay segment is expected to dominate the global hospital-acquired disease testing market revenue. The increase in cancer cases, infectious disorders, and sudden pandemic outbreaks are all factors contributing to the segment's revenue growth. 

Hospital-Acquired Disease Testing Market by Application

Based on application, the global hospital-acquired disease testing market is segmented into disease testing and drug-resistance testing. 

The drug resistance testing segment is expected to dominate the global hospital-acquired disease testing market in terms of revenue share during the forecast period.

Hospital-Acquired Disease Testing Market by Infection Type

[987054]

Based on infection type, the global hospital-acquired disease testing market is segmented into hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, and urinary tract infections (UTI). 

The urinary tract infections (UTI) segment is expected to account for the highest revenue growth during the forecast period owing to which the market opportunity for infection diagnostics acquired in hospitals can be credited. Furthermore, pneumonia is also a common diagnosis among hospitalized patients.

Hospital-Acquired Disease Testing Market by End User

Based on end users, the global hospital-acquired disease testing market is segmented into hospitals, standalone laboratories, and others. 

The hospital segment dominates the market revenue share owing to the rapid rise of patients and the pandemic outbreak.

Hospital-Acquired Disease Testing Market by Region

Based on region, the global hospital-acquired disease testing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America is expected to continue its dominance during the forecast period and account for the largest revenue share in the global market. This is due to an aging population, stringent regulatory standards, an improved healthcare infrastructure, a rise in hospital stays, and a rising risk of getting an infection acquired in the hospital.

The market in the Asia Pacific is expected to register the fastest revenue growth during the forecast period due to the region's laxer regulations, rising demand for cutting-edge drugs and treatments, and rising medical tourism.

Competitive Landscape

The prominent market players in the global hospital-acquired disease testing market include:

  • Abbott Laboratories 
  • Bayer AG
  • Becton Dickinson & Company
  • Danaher Corporation 
  • Sotera Health Company
  • Ecolab, Inc.
  • Hologic, Inc.
  • Johnson & Johnson Pvt. Ltd.
  • Getinge AB
  • Merck KgaA
  • Pfizer Inc.
  • Advanced Sterilization Products (ASP)
  • Steris Plc
  • Pal International
  • Continental Equipment Company
  • BGS (Beta-Gamma-Service GmbH & Co, Kg)
  • C.B.M. S.r.l. 
  • Reckitt Benckiser

Strategic development

  • In January 2021, to diversify its enormous range of sterilizing services, STERIS acquired Cantel, a global provider of infection prevention services and products through a US subsidiary.
  • In March 2021, a Sotera Health Company subsidiary named Sterigenics S.A.S. increased the sterilizing capacity of Europe by expanding its ethylene oxide (EO) facility in Rantigny, France.
  • In August 2020, Lotron, a significant North American outsourced provider of E-beam sterilizing services, was acquired by Sotera Health Company. Through this acquisition, the company was able to increase the scope of its electron beam (E-beam) operations and diversify its Stringencies business.
  • In November 2020, Key Surgical, a major provider of goods for the operating room, endoscopy, and sterile processing, was acquired by STERIS. The company's product line and STERIS' revenue increased by 35% as a result of this transaction.

Frequently Asked Questions About This Report

North America is the key revenue growth region during the forecast period which dominates the global hospital-acquired disease testing market in terms of revenue share.

The increasing incidence of hospital-acquired infections and increasing launches of advanced and efficient testing tools and kits are key driving factors for the market revenue growth of hospital-acquired disease testing.

The prominent market players operating in the global hospital-acquired disease testing market include Abbott Laboratories, Bayer AG, Becton Dickinson & Company, and others.

The global hospital-acquired disease testing market is expected to reach US$ 7.14 billion by 2030.

The global hospital-acquired disease testing market is expected to register a revenue CAGR of 7.7% during the forecast period.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2.  Base Year – 2021
      3.  Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trend (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET - ANALYSIS & FORECAST, BY PRODUCT
    1. Instruments
    2.  Reagents
    3.  Consumables
  6. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET - ANALYSIS & FORECAST, BY TEST TYPE
    1. Molecular Diagnostics
    2. Immunoassay
    3. Others
  7. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Disease Testing
    2. Drug-Resistance Testing
  8. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET - ANALYSIS & FORECAST, BY INFECTION TYPE
    1. Hospital Acquired Pneumonia
    2. Bloodstream Infections
    3. Surgical Site Infections
    4. Gastrointestinal Infections
    5.  Urinary Tract Infections
  9. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospital
    2. Standalone Laboratories
    3. Others
  10. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Hospital Acquired Disease Testing   Market
      1. North America Hospital Acquired Disease Testing   Market, by Product
      2. North America Hospital Acquired Disease Testing   Market, by Test Type
      3. North America Hospital Acquired Disease Testing   Market, by Application
      4. North America Hospital Acquired Disease Testing   Market, by Infection Type
      5. North America Hospital Acquired Disease Testing   Market, by End User
      6. North America Hospital Acquired Disease Testing   Market, by Country
        1. U.S.
          1. U.S. Hospital Acquired Disease Testing   Market, by Product
          2. U.S. Hospital Acquired Disease Testing   Market, by Test Type
          3. U.S. Hospital Acquired Disease Testing   Market, by Application
          4. U.S. Hospital Acquired Disease Testing   Market, by Infection Type
          5. U.S. Hospital Acquired Disease Testing   Market, by End User
        2. Canada
          1. Canada Hospital Acquired Disease Testing   Market, by Product
          2. Canada Hospital Acquired Disease Testing   Market, by Test Type
          3. Canada Hospital Acquired Disease Testing   Market, by Application
          4. Canada Hospital Acquired Disease Testing   Market, by Infection Type
          5. Canada Hospital Acquired Disease Testing   Market, by End User
    2. Europe Hospital Acquired Disease Testing   Market
      1. Europe Hospital Acquired Disease Testing   Market, by Product
      2. Europe Hospital Acquired Disease Testing   Market, by Test Type
      3. Europe Hospital Acquired Disease Testing   Market, by Application
      4. Europe Hospital Acquired Disease Testing   Market, by Infection Type
      5. Europe Hospital Acquired Disease Testing   Market, by End User
      6. Europe Hospital Acquired Disease Testing   Market, by Country/Region
        1. Germany
          1. Germany Hospital Acquired Disease Testing   Market, by Product
          2. Germany Hospital Acquired Disease Testing   Market, by Test Type
          3. Germany Hospital Acquired Disease Testing   Market, by Application
          4. Germany Hospital Acquired Disease Testing   Market, by Infection Type
          5. Germany Hospital Acquired Disease Testing   Market, by End User
        2. U.K.
          1. U.K. Hospital Acquired Disease Testing   Market, by Product
          2. U.K. Hospital Acquired Disease Testing   Market, by Test Type
          3. U.K. Hospital Acquired Disease Testing   Market, by Application
          4. U.K. Hospital Acquired Disease Testing   Market, by Infection Type
          5. U.K. Hospital Acquired Disease Testing   Market, by End User
        3. Spain
          1. Spain Hospital Acquired Disease Testing   Market, by Product
          2. Spain Hospital Acquired Disease Testing   Market, by Test Type
          3. Spain Hospital Acquired Disease Testing   Market, by Application
          4. Spain Hospital Acquired Disease Testing   Market, by Infection Type
          5. Spain Hospital Acquired Disease Testing   Market, by End User
        4. Italy 
          1. Italy Hospital Acquired Disease Testing   Market, by Product
          2. Italy Hospital Acquired Disease Testing   Market, by Test Type
          3. Italy Hospital Acquired Disease Testing   Market, by Application
          4. Italy Hospital Acquired Disease Testing   Market, by Infection Type
          5. Italy Hospital Acquired Disease Testing   Market, by End User
        5. France
          1. France Hospital Acquired Disease Testing   Market, by Product
          2. France Hospital Acquired Disease Testing   Market, by Test Type 
          3. France Hospital Acquired Disease Testing   Market, by Application
          4. France Hospital Acquired Disease Testing   Market, by Infection Type
          5. France Hospital Acquired Disease Testing   Market, by End User
        6. Rest of Europe 
          1. Rest of Europe Hospital Acquired Disease Testing   Market, by Product
          2. Rest of Europe Hospital Acquired Disease Testing   Market, by Test Type
          3. Rest of Europe Hospital Acquired Disease Testing   Market, by Application
          4. Rest of Europe Hospital Acquired Disease Testing  Market, by Infection Type
          5. Rest of Europe Hospital Acquired Disease Testing   Market, by End User
    3. Asia Pacific Hospital Acquired Disease Testing   Market
      1. Asia Pacific Hospital Acquired Disease Testing   Market, by Product
      2. Asia Pacific Hospital Acquired Disease Testing   Market, by Test Type
      3. Asia Pacific Hospital Acquired Disease Testing   Market, by Application
      4. Asia Pacific Hospital Acquired Disease Testing   Market, by Infection Type
      5. Asia Pacific Hospital Acquired Disease Testing   Market, by End User
      6. Asia Pacific Hospital Acquired Disease Testing   Market, by Country/Region
        1. China
          1. China Hospital Acquired Disease Testing   Market, by Product
          2. China Hospital Acquired Disease Testing   Market, by Test Type
          3. China Hospital Acquired Disease Testing   Market, by Application
          4. China Hospital Acquired Disease Testing   Market, by Infection Type
          5. China Hospital Acquired Disease Testing   Market, by End User
        2. Japan
          1. Japan Hospital Acquired Disease Testing   Market, by Product
          2. Japan Hospital Acquired Disease Testing   Market, by Test Type
          3. Japan Hospital Acquired Disease Testing   Market, by Application
          4. Japan Hospital Acquired Disease Testing   Market, by Infection Type
          5. Japan Hospital Acquired Disease Testing   Market, by End User
        3. India
          1. India Hospital Acquired Disease Testing   Market, by Product
          2. India Hospital Acquired Disease Testing   Market, by Test Type
          3. India Hospital Acquired Disease Testing   Market, by Application
          4. India Hospital Acquired Disease Testing   Market, by Infection Type
          5. India Hospital Acquired Disease Testing   Market, by End User
        4. South Korea
          1. South Korea Hospital Acquired Disease Testing   Market, by Product
          2. South Korea Hospital Acquired Disease Testing   Market, by Test Type
          3. South Korea Hospital Acquired Disease Testing   Market, by Application
          4. South Korea Hospital Acquired Disease Testing  Market, by Infection Type
          5. South Korea Hospital Acquired Disease Testing   Market, by End User
        5. Australia
          1. Australia Hospital Acquired Disease Testing   Market, by Product
          2. Australia Hospital Acquired Disease Testing   Market, by Test Type
          3. Australia Hospital Acquired Disease Testing   Market, by Application
          4. Australia Hospital Acquired Disease Testing   Market, by Infection Type
          5. Australia Hospital Acquired Disease Testing   Market, by End User
        6. Rest of Asia Pacific 
          1. Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Product
          2. Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Test Type
          3. Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Application
          4. Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Infection Type
          5. Rest of Asia Pacific Hospital Acquired Disease Testing Market, by End User
    4. Rest of the World Hospital Acquired Disease Testing   Market
      1. Rest of the World Hospital Acquired Disease Testing  Market, by Product
      2. Rest of the World Hospital Acquired Disease Testing  Market, by Test Type
      3. Rest of the World Hospital Acquired Disease Testing  Market, by Application
      4. Rest of the World Hospital Acquired Disease Testing  Market, by Infection Type
      5. Rest of the World Hospital Acquired Disease Testing  Market, by End User
      6. Rest of the World Hospital Acquired Disease Testing  Market, By Region
        1. Latin America
          1. Latin America Hospital Acquired Disease Testing Market, by Product
          2. Latin America Hospital Acquired Disease Testing Market, by Test Type
          3. Latin America Hospital Acquired Disease Testing Market, by Application
          4. Latin America Hospital Acquired Disease Testing Market, by Infection Type
          5. Latin America Hospital Acquired Disease Testing Market, by End User
        2. Middle East & Africa
          1. Middle East & Africa Hospital Acquired Disease Testing Market, by Product
          2. Middle East & Africa Hospital Acquired Disease Testing Market, by Test Type
          3. Middle East & Africa Hospital Acquired Disease Testing Market, by Application
          4. Middle East & Africa Hospital Acquired Disease Testing Market, by Infection Type
          5. Middle East & Africa Hospital Acquired Disease Testing Market, by End User
  11. COMPANY PROFILES        
    1. Abbott Laboratories 
      1. Business Snapshot 
      2. Products/Services Offered
      3. Financial Details*
      4. Strategic Developments
    2. Bayer AG
    3. Becton Dickinson & Company
    4. Danaher Corporation 
    5. Sotera Health Company
    6. Ecolab, Inc.
    7. Hologic, Inc.
    8. Johnson & Johnson Pvt. Ltd.
    9. Getinge AB
    10. Merck KgaA
    11. Pfizer Inc.
    12. Advanced Sterilization Products (ASP)
    13. Steris Plc
    14. Pal International
    15. BGS (Beta-Gamma-Service GmbH & Co, Kg)
    16. C.B.M. S.r.l. 
    17. Continental Equipment Company
    18. Reckitt Benckiser

*Insights on financial performance is subject to availability of information in public domain


Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Hospital Acquired Disease Testing Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Hospital Acquired Disease Testing Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports